WALTHAM, Mass.--(BUSINESS WIRE)--Artisan Pharma, Inc. today announced that Gary Shearman, Ph.D. has joined the board of directors of Artisan Pharma, Inc., bringing with him more than 25 years of senior management and leadership experience in the pharmaceutical and venture capital industries. Dr. Shearman is currently President and Chief Executive Officer of Neuro-Hitech, Inc. (www.neurohitech.com) (NASDAQ:NHPI), a public biopharmaceutical company focused on developing innovative new drugs for the treatment of neurodegenerative diseases. He is also Chairman of the board of directors of Nereus Pharmaceuticals, Inc. (www.nereuspharm.com), a privately held biotechnology company. From 2001 – 2007, Dr. Shearman was Chairman and Managing Director of HBM Advisors USA, LLC, a provider of investment advisory services for HBM Partners (Cayman) Ltd. the investment manager for all HBM vehicles including HBM Bioventures and HBM Biocapital. Prior to his tenure at HBM, Dr. Shearman held a number of senior positions in the pharmaceutical industry, most recently as Senior Vice President of Pharmaceutical Drug Development and Deputy Head of Research and Development at Rhone Poulenc Rorer (now Sanofi-Aventis). While at Rhone Poulenc, he was intimately involved with the development of LOVENOX®, the low molecular weight heparin anticoagulant, experience which will be fully leveraged at Artisan.
